Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016
Published Jun 08, 2016
93 pages — Published Jun 08, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016, provides an overview of the Sicca Syndrome (Sjogren) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sicca Syndrome (Sjogren), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sicca Syndrome (Sjogren) and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Sicca Syndrome (Sjogren)
- The report reviews pipeline therapeutics for Sicca Syndrome (Sjogren) by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Sicca Syndrome (Sjogren) therapeutics and enlists all their major and minor projects
- The report assesses Sicca Syndrome (Sjogren) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Sicca Syndrome (Sjogren)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sicca Syndrome (Sjogren)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by und

  
Source:
Document ID
GMDHC8187IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables51
  List of Figures61
Introduction71
  Global Markets Direct Report Coverage71
Sicca Syndrome (Sjogren) Overview81
Therapeutics Development92
  Pipeline Products for Sicca Syndrome (Sjogren) Overview91
  Pipeline Products for Sicca Syndrome (Sjogren) Comparative Analysis101
Sicca Syndrome (Sjogren) Therapeutics under Development by Companies111
Sicca Syndrome (Sjogren) Therapeutics under Investigation by Universities/Institutes121
Sicca Syndrome (Sjogren) Pipeline Products Glance133
  Late Stage Products131
  Clinical Stage Products141
  Early Stage Products151
Sicca Syndrome (Sjogren) Products under Development by Companies161
Sicca Syndrome (Sjogren) Products under Investigation by Universities/Institutes171
Sicca Syndrome (Sjogren) Companies Involved in Therapeutics Development1812
  Akari Therapeutics, Plc181
  Amgen Inc.191
  Ampio Pharmaceuticals, Inc.201
  Biogen, Inc.211
  Bristol-Myers Squibb Company221
  Eli Lilly and Company231
  F. Hoffmann-La Roche Ltd.241
  GlaxoSmithKline Plc251
  MedImmune, LLC261
  Redx Pharma Plc271
  Toleranzia AB281
  UCB S.A.291
Sicca Syndrome (Sjogren) Therapeutics Assessment309
  Assessment by Monotherapy Products301
  Assessment by Target312
  Assessment by Mechanism of Action332
  Assessment by Route of Administration352
  Assessment by Molecule Type372
Drug Profiles3932
  abatacept - Drug Profile391
    Product Description391
    Mechanism of Action391
    R&D Progress394
  ABS-11 - Drug Profile431
    Product Description431
    Mechanism of Action431
    R&D Progress431
  AMG-557 - Drug Profile441
    Product Description441
    Mechanism of Action441
    R&D Progress442
  Ampion - Drug Profile461
    Product Description461
    Mechanism of Action461
    R&D Progress462
  belimumab - Drug Profile481
    Product Description481
    Mechanism of Action481
    R&D Progress484
  BIIB-063 - Drug Profile521
    Product Description521
    Mechanism of Action521
    R&D Progress521
  CDZ-173 - Drug Profile531
    Product Description531
    Mechanism of Action531
    R&D Progress531
  Cellular Immunotherapy for Type 1 Diabetes and Sjogrens Syndrome - Drug Profile541
    Product Description541
    Mechanism of Action541
    R&D Progress541
  CFZ-533 - Drug Profile551
    Product Description551
    Mechanism of Action551
    R&D Progress552
  Coversin - Drug Profile571
    Product Description571
    Mechanism of Action571
    R&D Progress572
  GSK-2618960 - Drug Profile591
    Product Description591
    Mechanism of Action591
    R&D Progress591
  IMSO-001 - Drug Profile601
    Product Description601
    Mechanism of Action601
    R&D Progress601
  LY-3090106 - Drug Profile611
    Product Description611
    Mechanism of Action611
    R&D Progress611
  MEDI-4920 - Drug Profile621
    Product Description621
    Mechanism of Action621
    R&D Progress621
  MEDI-7734 - Drug Profile631
    Product Description631
    Mechanism of Action631
    R&D Progress631
  RDX-002 - Drug Profile641
    Product Description641
    Mechanism of Action641
    R&D Progress641
  Recombinant Protein for Sjogren's Syndrome - Drug Profile651
    Product Description651
    Mechanism of Action651
    R&D Progress651
  RG-7625 - Drug Profile661
    Product Description661
    Mechanism of Action661
    R&D Progress661
  seletalisib - Drug Profile671
    Product Description671
    Mechanism of Action671
    R&D Progress671
  VAY-736 - Drug Profile681
    Product Description681
    Mechanism of Action681
    R&D Progress682
  VM-200 - Drug Profile701
    Product Description701
    Mechanism of Action701
    R&D Progress701
Sicca Syndrome (Sjogren) Recent Pipeline Updates7118
Sicca Syndrome (Sjogren) - Dormant Projects891
Sicca Syndrome (Sjogren) Discontinued Products901
Sicca Syndrome (Sjogren) Product Development Milestones911
  Featured News &Press Releases911
    Apr 22, 2011: Breakthrough study links Type 1 diabetes and Sjogren s syndrome911
Appendix922
  Methodology921
  Coverage921
  Secondary Research921
  Primary Research921
  Expert Panel Validation921
  Contact Us921
  Disclaimer931

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016" Jun 08, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Sicca-Syndrome-Sjogren-Pipeline-Review-H1-2016-2088-15919>
  
APA:
Global Markets Direct - Market Research. (2016). Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016 Jun 08, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Sicca-Syndrome-Sjogren-Pipeline-Review-H1-2016-2088-15919>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.